Sébastien Papot Selected Research

Sébastien Papot Research Topics

27	Neoplasms (Cancer) 08/2023 - 02/2007
4	Glioblastoma (Glioblastoma Multiforme) 01/2015 - 04/2010
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	COVID-19 01/2023
1	Infections 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2022
1	Lewis Lung Carcinoma 01/2022
1	Hypoxia (Hypoxemia) 01/2020
1	Dehydration (Water Stress) 01/2019
1	Adenocarcinoma 12/2018
1	Breast Neoplasms (Breast Cancer) 12/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2013
1	Lung Neoplasms (Lung Cancer) 09/2008

17	ProdrugsIBA 05/2023 - 02/2007
9	GlucuronidesIBA 11/2020 - 02/2007
8	GlucuronidaseIBA 01/2023 - 05/2012
7	EnzymesIBA 05/2023 - 09/2014
5	AlbuminsIBA 05/2023 - 05/2012
5	GalactosidasesIBA 11/2015 - 06/2011
4	monomethyl auristatin EIBA 05/2023 - 09/2013
4	cyclopamineIBA 01/2015 - 04/2010
3	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 12/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 05/2012
3	Folic Acid (Vitamin M)FDA LinkGeneric 11/2015 - 06/2011
2	Histone Deacetylase InhibitorsIBA 08/2023 - 09/2008
2	Glycoside Hydrolases (Endoglycosidases)IBA 05/2023 - 01/2023
2	CyclodextrinsIBA 01/2022 - 07/2021
1	MicellesIBA 08/2023
1	entinostat (MS 275)IBA 08/2023
1	Bevacizumab (Avastin)FDA Link 01/2023
1	CaspasesIBA 10/2022
1	MetalsIBA 10/2022
1	Interleukin-2 (IL2)IBA 07/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Cytotoxins (Cytolysins)IBA 01/2020
1	Volatile Organic CompoundsIBA 12/2019
1	AntigensIBA 04/2019
1	Hydroxamic Acids (Hydroxamic Acid)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 10/2018
1	Ado-Trastuzumab EmtansineIBA 12/2017
1	Angiogenesis InhibitorsIBA 05/2016
1	Rotaxanes (Rotaxane)IBA 04/2015
1	AlkaloidsIBA 09/2014
1	Antimitotic AgentsIBA 11/2012
1	tacedinaline (CI 994)IBA 09/2008

10	Drug Therapy (Chemotherapy) 05/2023 - 02/2007
4	Therapeutics 05/2023 - 05/2017